Yogatel 80 Tablet contains Telmisartan 80 mg, an angiotensin II receptor antagonist primarily used in the management of hypertension. By selectively blocking the binding of angiotensin II to the AT1 receptor, Telmisartan promotes vasodilation and reduces aldosterone secretion, leading to decreased peripheral vascular resistance and lowered blood pressure. This mechanism helps prevent complications associated with hypertension, such as stroke, myocardial infarction, and renal impairment. Yogatel 80 is indicated for the treatment of essential hypertension and may be prescribed alone or in combination with other antihypertensive agents to achieve optimal blood pressure control. It is also beneficial in reducing cardiovascular risk in patients with left ventricular hypertrophy or high cardiovascular risk profiles. The tablet is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and tolerability. Common adverse effects include dizziness, headache, and fatigue, while serious side effects are rare but may involve hypotension or renal dysfunction. Caution is advised in patients with renal or hepatic impairment and during pregnancy. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy with Yogatel 80 Tablet to ensure safety and efficacy.